“An acceleration should be made with the PNRR also because there are clear ideas about what the organization and the needs of patients are. For example, access to innovative orphan drugs must be accelerated, ensuring their availability throughout the territory; and then there is the great issue of plasma derivatives to be taken into consideration, which are often the only therapies to reduce blood pathologies “. Thus the senator of Forza Italia, member of the Health Commission of Palazzo Madama, Maria Rizzotti, in her speech at the initiative organized by FedEmo entitled “Let’s make prospects active”, on the occasion of the XVIII World Hemophilia Day, held at Palazzo Rospigliosi in Rome. “The demand for this product – explains Rizzotti – continues to grow every year, making the gap between supply and demand, in particular for immunoglobulins, chronically unsatisfactory on a national, European and global level. I submitted a question to the Minister of Health to ask him if he does not consider it appropriate to equip the country with a procurement strategy because we are at a time when, with the pandemic, blood donations have decreased but now donors are just waiting to to be able to have the pick-up doctor who, on the other hand, is employed in the hospital wards for Covid. So I made the proposal to also use the trainees of the last year of the specialties to be able to help the blood collection centers “. “I hope that the search for personalized therapies and the true strengthening of proximity medicine and, above all, the uniformity of provision of services and services, can be increasingly supported”, concludes the senator.
Welcome! Log into your account
Recover your password
A password will be e-mailed to you.